Company intelligence / Profile preview

Virionics

Irvine, California, United States

Ownership: Private
Development stage: Other

Overview

Virionics is a biotechnology company based in Irvine, California, that specializes in the development and production of high-quality reagents and diagnostic tools for the study of viral pathogens. Founded by experts in virology, the company provides a comprehensive catalog of monoclonal antibodies and recombinant proteins targeting emerging viruses, including SARS-CoV-2 and various Arenaviruses. Virionics supports the global research community by offering specialized tools for viral detection, characterization, and vaccine development. Their business model focuses on the commercialization of research-grade reagents and the development of diagnostic assays for infectious diseases.

Therapeutic areas: Infectious Diseases
Modalities: Monoclonal antibodyRecombinant protein
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Virionics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Virionics.

Explore the full profile